Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Intra-Cellular Therapies Inc market cap is $7.63B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Intra-Cellular Therapies Inc 52 week high is $84.89 as of April 25, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Intra-Cellular Therapies Inc 52 week low is $45.50 as of April 25, 2024.
Intra-Cellular Therapies Inc stock price today is $71.50.
Intra-Cellular Therapies Inc stock price yesterday was $73.12.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Intra-Cellular Therapies Inc’s P/E ratio is -50.15.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Intra-Cellular Therapies Inc P/B ratio is 11.9158.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Intra-Cellular Therapies Inc's EBITDA is -40.37.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Intra-Cellular Therapies Inc 50-day moving average is $69.39.
Intra-Cellular Therapies Inc has 610 employees.